CYSTEIN PROTEASE INHIBITOREN

European patent · EP1358183 · Deleted

Register entry

Publication number
EP1358183
Application number
EP01273876
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 16, 2001
Published
Nov 5, 2003
Granted
Apr 12, 2006
Deleted
Nov 30, 2007
Reason
Annual fee unpaid
IPC classes
C07D 407/12 (2006.01)
C07D 409/12 (2006.01)
C07D 309/14 (2006.01)
C07D 307/22 (2006.01)
A61K 31/365 (2006.01)
A61K 31/343 (2006.01)
A61P 19/10 (2006.01)
Priority
US 252802 P 17.11.2000
US 252840 P 17.11.2000
PCT application
PCT/IB2001/002906 16.11.2001
PCT publication
WO2002/088106 07.11.2002
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2008

    Deleted, fee unpaid

    Published in Swissreg on 01.07.2008

  2. Jul 31, 2006

    Agent entered

    Representative
    PA Aldo Römpler, Schützengasse 34, Postfach 229, 9410 Heiden

    Published in +pat+ No 14 in 2006

  3. Apr 13, 2006

    Granted

    Published in +pat+ No 7 in 2006

Parties

Holder

MEDIVIR AB

Lunastigen 7, 141 44 Huddinge, SE

Agent

PA Aldo Römpler

Schützengasse 34 Postfach 229, 9410 Heiden

Inventor

QUIBELL, Martin

Hinton CB1 Cambridgeshire, GB

TAYLOR, Steven

Didcot, Oxon, OX11 7AU, GB

GRABOWSKA, Urszula, Medivir UK Ltd.

Cambridge CB1 9PT, GB

NILSSON, Magnus, Medivir AB

14144 Huddinge, SE

MORISSON, Veronique, Medivir UK Ltd.

Cambridge CB1 9PT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.